Skip to content

Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment

Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05359159
Enrollment
100
Registered
2022-05-03
Start date
2021-02-01
Completion date
2024-02-29
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Long-COVID, post-COVID, SarS-CoV2

Brief summary

People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence pf them.Investigators intend to follow over time the post-infectious phase of patients discharged from sub-intensive care unit. The aim is to identify symptoms and their frequency of presentation in the SARS-CoV-2 population in the post-acute period.

Interventions

OTHERData collection

Data collection

Sponsors

University of L'Aquila
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients over 18

Exclusion criteria

* Patients under 18

Design outcomes

Primary

MeasureTime frameDescription
Greater understanding of SARS-CoV-2 disease24 monthsGreater understanding of SARS-CoV-2 disease and its long-term manifestations. To this end, the clinical manifestations, any alterations in laboratory and instrumental parameters will be evaluated to identify organ damages and calculate its prevalence

Secondary

MeasureTime frameDescription
Measurement of psychological impact of SARS-CoV-2 disease24 monthsUnderstanding the impact of the disease and its sequelae on daily life and the impact on the psychological aspect of the person;

Countries

Italy

Contacts

Primary ContactClara Balsano
clara.balsano@univaq.it00390862434774

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026